Cargando...
Insulin-mimetic compound hexaquis (benzylammonium) decavanadate is antilipolytic in human fat cells
AIM: To assess in rodent and human adipocytes the antilipolytic capacity of hexaquis(benzylammonium) decavanadate (B6V10), previously shown to exert antidiabetic effects in rodent models, such as lowering free fatty acids (FFA) and glucose circulating levels. METHODS: Adipose tissue (AT) samples wer...
Guardado en:
| Publicado en: | World J Diabetes |
|---|---|
| Autores principales: | , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Baishideng Publishing Group Inc
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5394734/ https://ncbi.nlm.nih.gov/pubmed/28465791 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4239/wjd.v8.i4.143 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|